Biologics
-
Biologics
Surgalign Launches New Device for Bone Formation
ViBone Moldable is the newest orthobiologics solution of Surgalign’s bone graft portfolio to support spinal fusion.GlobeNewswire 01.13.21
-
Biologics
Locate Bio’s CognitOss for Chronic Osteomyelitis Earns Breakthrough Status
Combines resorbable bone graft with bone healing properties and proprietary dual-phasic release of antibiotics.Business Wire 01.11.21
-
Biologics
Evonik Launches Next-Generation PEEK Biomaterial for Medtech Applications
VESTAKEEP iC4800's mechanical properties are similar to those of human bone.Evonik Industries AG 12.03.20
-
Biologics | Spine/Neurology
Surgalign, Aziyo Biologics Expand Distribution Deal
Boosts availability of ViBone Moldable, a next-gen moldable cellular bone matrix product.GlobeNewswire 11.17.20
-
Biologics
i-FACTOR + Matrix Launches in Canada
Becomes the first market to offer the i-FACTOR+ MATRIX.Cerapedics 11.05.20
-
Biologics
Orthobiologics Market to Reach $8.7 Billion By 2027
Approval and launch of new products are expected to propel the market's growth.Coherent Market Insights 10.29.20
-
Biologics
Avitus Orthopaedics Launches Bone Harvester
Empowers surgeons to tackle a full spectrum of bone harvesting needs.Avitus Orthopaedics 10.27.20
-
Biologics
Biologica Technologies Introduces OsseoGEN Cellular Bone Matrix
Company also announces first surgical cases using the product.PR Newswire 10.09.20
-
Biologics
Bioventus Reaches Two Million DUROLANE Treatments Worldwide
The original single-injection hyaluronic acid therapy has helped patients in nearly 30 countries.Business Wire 09.23.20
-
Biologics
Cerapedics Receives Canadian Approval for Next-Gen Bone Graft
The first country to approve the commercial launch of i-FACTOR+ Matrix.Cerapedics 09.16.20
-
3-D Printing/Additive Mfg. | Biologics
ODT’s Editorial Advisory Board Reflects on 15 Years
ODT reached out to members of its Editorial Advisory Board to help celebrate the brand's 15th birthday.Michael Barbella, Managing Editor 09.15.20
-
Biologics
DiscGenics Names Former Medtronic Spine Exec as CFO
Jeff Poole has over 13 years of progressive finance leadership experience in medical devices.PR Newswire 09.10.20
-
Biologics | Spine/Neurology
First Use of Bioventus' SIGNAFUSE Bioactive Bone Graft in Strip Format
SIGNAFUSE strips were placed in the posterolateral gutters of the patient’s spine for posterolateral lumbar fusion.Business Wire 09.02.20
-
Biologics
FDA OKs SurGenTec's OsteoFlo NanoPutty Quadphasic Synthetic Bone Graft
OsteoFlo requires no mixing, reconstituting, or preparation prior to use.Business Wire 08.26.20
-
Biologics
Bioventus Invests in CartiHeal with Option to Acquire
Companies have agreed on an option structure under which Bioventus will acquire CartiHeal shortly after FDA approval of the Agili-C implant.Bioventus 07.16.20
-
Biologics
FDA Clears Altapore Shape Bioactive Bone Graft
Designed to enhance bone growth and help achieve fusion.Business Wire 07.09.20
-
Biologics
Aziyo Biologics Launches OsteGro V
Company expands regenerative medicine product portfolio and leverages proprietary processing platform to protect and preserve native bone cells.Aziyo Biologics 07.02.20
-
Biologics
FDA Clears Strip Format of Bioventus’ Signafuse Bioactive Bone Graft
A bone graft substitute intended for use in bony voids or gaps of the skeletal system.Bioventus 06.25.20
-
Biologics
SIRAKOSS Receives U.S. FDA 510(k) Clearance for Osteo3 ZP Putty
Combines best-in-class bone repair with intraoperative ease-of-use for spine and trauma bone grafting applications.SIRAKOSS Ltd. 06.17.20
-
Biologics
Smith+Nephew's Regeneten Bioinductive Implant Receives CE Mark
Supports the body's natural healing response to facilitate tissue growth for rotator cuff repairs.PR Newswire 06.16.20
